NATUR-LEAF ®

Sterols and Sterolins - a
Natural Health Supplement

ANNALS OF
LA TOUR INTERNATIONAL SOCIETY OF GERONTOLOGY
Mexico
Volume XX, 16, 1999

DEGENERATIVE DISEASES

By PETER R. ROTHSCHILD
Copyright © 1999 by Peter R. Rothschild. All rights reserved.
No part of this publication may be used or reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system without written permission from Peter R. Rothschild.

ABSTRACT

Degenerative Diseases

Author: Peter R. Rothschild; Source: Annals of La Tour International Society of Gerontology, Mexico, Volume XX, 16, 1999

Discussion: Natural sterols, combined with sterolins - their native glucosides - represent an all-natural formula isolated from a sophisticated blend of herbal components that breed true-to-life factors, which intelligently gird all necessities of a human body's immune response. This is of paramount importance not only for general disease prevention, but also for specific immune enhancement in degenerative diseases and various aging processes as well. This appears particularly evident when the vast data processing mechanics of a human body is thoroughly scrutinized.

DEGENERATIVE DISEASES

By
Peter R. Rothschild

Immunotolerance is a fundamental property of the immune system, that provides the potential for self/non-self discrimination, so that the immune system can protect the host from exogenous pathogens without reacting against itself. Because, when the immune system reacts against itself, it generates autoimmune diseases.

Until relatively recently, it was believed that the self/non-self discrimination was a simple matter of eradicating autoreactive cells in the thymus. However, at present we have already learned that the maintenance of the immunotolerance is quite a complex process. Autoreactive cells, such as the ones that interact with the brain for instance, are not eradicated, but can also be found in normal individuals. The reason for which these cells are activated causing diseases in some individuals, while in others the same type continue harmless constitutes one of the greatest puzzles in contemporary immunology. The way to control and to neutralize the autoimmune processes represents to this day one of the greatest challenges for clinical medicine. It is precisely to the topic of patho-histological dynamics of the herein referred to diseases, this essay is dedicated to, with the intention to suggest solutions to this paramount question.

The present study of these mechanisms, is precisely addressing possible solutions for this challenge. Until quite recently, an unending universal contusion existed concerning the paradoxical discoveries revealed by the scientists dedicated to the exploration of the mechanisms that govern the immune response. First of all, the researchers did not consider the circumstance that the thymus cells constitute part of the myelopoietic cell line, that originates in the bone marrow. These cells, white under development, bear surface markers, which identify each cell type. These markers undergo changes responding to the maturing of the cells. Thus, immature thymocytes bear CD1 markers. Some migrate to the thymus only during the advanced phases of the gestation. Others continue migrating - however, in an ever-diminishing volume - during the individual's entire life. Nevertheless, massive migration only takes place during the first 2 years of age, and between the 13th and 14th year of age That is, immediately after puberty. As they mature and emerge from the bone marrow, the thymocytes modify their CD-1 markers to lymphocytic CD-3. When a CD-2 cell is exposed to an antigen and induces an immune response, it turns into a CD-4 type - a lymphocyte assistant/inductor - and remains committed to that particular antigen, developing an appropriate CD-4 marker on its surface.

The lymphocytes known as NK (Natural Killers) are patrolling sentinels that locate and kill invading germs and viruses. These assassin cells ordinarily exist in great profusion. There are some 1,200 in each microliter of blood. To this date, 24 types of T-lymphocyte families have been identified. The differentiations can be distinguished by the second of two proteinic receptors, identified as Alfa and Beta chains that protrude in a 'N" form from their membranes. When a virus or a germ glides between the two arms of the V, the T-lymphocyte captures and destroys it. In this manner, the thus involved T-lymphocytes auto-replicate without delay, and its descendants already remain committed - virtually fine-tuned - to attack all identical viruses or other antigens, against which the original ones became sensitized. The immune system of each healthy human individual commands its own private legion of strong killer T-lymphocytes.

Other T-cells become suppressors - cytotoxins - that bear CD-8 markers (also known as T8). Once they are "tuned" to a specific type of antigen, the thus exposed to T-lymphocyte remains committed to that particular type for life, but only provided that the availability of appropriate endogenous thymus hormones should be not restricted.

Comparable mechanisms also govern the procreation of B-lymphocytes, which are virtual ambulatory micro-factories of antibodies similarly equipped to become precision-tuned against almost any type of antigen.

Having thus canvassed a few of the more important immune mechanisms, we shall now focus on the essential topic of this essay. Completely regardless of how improbable it may seem, light definitely does exist within our cells.

The Russian professor of medicine Alexander Gurwitch empirically proved this surprising fact in 1922. Toward the end of the '30s, the notable American neuroanatomist Harold Burr, working at Yale University, designed a series of quite convincing experiments that substantiated Gurwitch's remarkable findings toward the end of the 30s. Eventually, after several decades of boisterous controversies, a team of German biophysicists irrefutably corroborated the postulate in 1975, under the direction of the professor Fritz Popp, conforming to the strictest requirements of the scientific method. Since then, numerous scientists in several parts of the world unquestionably confirmed that living cells indeed emit perceptible light.

In general terms, it is understood that photon refers to a "quantum of light". We know that a quantum constitutes the minutest and totally indivisible component of the Universe. Popp, who placed the prefix bio in front of photons, with the intention of suggesting that living cells may emit these, coined the expression 'biophoton".

Currently, there remain no doubts about the existence of such intracellular luminescence. (Not to be confused with the bioluminescence, generated, for example by the glowworms). Contemporary technology has developed powerful instruments capable of intensifying and measuring extremely minute light quantities, known as residual light, which prove unquestionably the existence of the biophotons.

It was also established that that this biophysical force not only pulsates in intensity, but also in frequency. Which explains quite satisfactorily the dynamics of its inherent mechanisms of interactions, which unfold among the different organs.

The question that remained to be answered was why do our cells emit light? Popp discovered that the light emitted by cells is a highly coherent light, comparable to the minute rays of coherent light produced by the components of the most advanced technology of data processing and transfer.

Popp explains "our organism must replace nearly ten million cells each minute." It is obvious that the information required to achieve such a feat, can only be processed at the speed of light. Apparently, such an overwhelming signal traffic of data transference and processing within any living organism - be that human, animal, vegetal or of insects - is achieved through biophotons with high precision. These minutest coherent rays of light are responsible for the maintenance and operation of the network of information linking all living cells, and likewise allow the continuous, unobstructed and intelligent updating of data.

However, there are some additional implications concerning this discovery that are not less amazing. Strange as it may seem, every time we consume some natural and fresh food, or their carefully preserved components, we indeed also ingest light, that - in one way or another - trigger certain activities in our system. In other words, when we ingest fresh food, their individual components emit luminous signals that inescapably participate in the development and management of certain biochemical endogenous processes. That is, the greater the capacity of light storage is in our nourishment, the more powerful will be their beneficial influence on our cells.

Here it is important to note, that these same principles begin to act - in fact, even more powerfully - when we administer food supplements that contain naturopathic factors, that originate from biotechnological sources, such as virgin plant, particularly sprout extracts, or animal organs processed by special technical means, that permit to preserve their light-storing capacity, and their ability to induce coherent biological light in their intracellular environments. Ultimately, the chief biomodulating mechanisms of the genes - both in charge of synthesis and lysis - are themselves contingent on their potential to generate high-precision coherent precursor light signals, capable of transcribing expressions linked to the specific cells they are addressing.

The physicist Popp declared "The human organism is not only a carnivorous, or vegetarian being, but also a consumer of light. In fact, it behaves like a luminivorous creature." Some of the scientists dedicated to biophotonic research suggest that, similarly to the hypotheses postulated by Burr, the light emitted by our cells constitutes part of a complex force field that surrounds - virtually wraps - our entire body, and governs our life processes. It seems obvious that not light alone governs individual events concerning our body, but, in a collective fashion, also commands the entire living system. Such signals must necessarily move at the speed of light and, at arriving at their respective destinations, interact intelligently with the data processing potential of the addressed sector.

What concerns us in the present context is that the findings of these physicists also corroborate the Theory of Sheldrake about morphogenic fields. Which, seems to offer once again a satisfactory explanation about the casting dynamics of the biophotonic activities. It appears evident that the systematic scrutiny of cyto-luminic phenomena offers solutions to numerous hitherto poorly understood biological paradigms, which to this date bewilder not only physicists, but biochemists and physicians as well.

The biophotonic investigations radically modify numerous biological and medical concepts that until very recently were considered classics. A completely new understanding of the live cell - and with it, of course, of very Nature - emerges in the wake of this scrutiny, which reveals that Life itself is based on complex interactive systems of energies, which are intelligently propagated. Ultimately, it seems that we are all beings of light.

Curiously, numerous statements in the Old Testament, and also in some postulates of the old Brahmans in the ancient Tibet, as well as in the Tao traditions and in the Tantric heritage, are evidently based on events that are at present scientifically sustainable. Parting from the fact that the existence and behavior of biophotons reveal an underlying and live energetic infrastructure in our system, an extensive scientific spectrum of enigmas becomes resolved from the experiments of Kaznatchejev and Kirlian, and the unobstructed light traffic inside the cells, to the true purpose of the pineal gland and to the blueprint of the DNA molecule in its capacity of a light pump, proves beyond doubt that biophotons act as principal organizers of living matter. They convert the chaos into order. They enable live cells to communicate intelligently among themselves. and corroborate the concept of Holographic Anatomy.

The hitherto accumulated evidence seems to indicate that the prelude to all degenerative diseases originates in a congenital or acquired malfunction in the genes that hampers biophotons in generating appropriate frequencies and intensities. Thus, our research was designed to explore the biophotonic interactions, which develop among the encephalic mass, thalamus, hypothalamus, the limbic area and, of course, the neuroglial system. Simultaneously, a protocol was designed to explore the thymus and pineal glands, the bone marrow and the Peyer's patches under the same biophotonic aegis.

For example, to this date Science has identified and isolated a variety of different of the thymic hormones. The most important of these are thymulin, thymopoietin, and the thymosin-alpha. In addition, two partially purified composites - fraction 5 of the thymosin and the thymostimuliri (TP-1) - also contain lymphocytic and epithelial cell constituents. The depuration of the thymic extracts requires complex technical and costly equipment. Thus, the commercially available extracts, regardless of what their respective manufacturers' claim, always contain at least one of the three main thymic hormones and/or of their active variants. The shortest thymic fraction still capable of producing demonstrable activity is a pentapeptide (fraction 5) of a molecular weight of around 800 Dalton. In addition to the effects already mentioned, once systemically diffused, the highly purified (HP) thymic fractions modulate virtually regulate - the production of a molecule called FasL. Some of the guardian lymphocytes, particularly the type-T, synthesize a molecule known as Fas-Ligand (FasL) that antagonizes abnormal cells. When the FasL becomes amalgamated with Fas - which is a receptor on numerous cell surfaces - apoptosis occurs. That is, after completing their task, the T-lymphocytes mutually destroy themselves. They merge with the Fas receptors in order to prevent their attack on healthy cells, as it frequently occurs, for example, in the liver of alcoholics. The speed of such reactions would be totally impossible without the mediation of coherent bioluminic signals. On the other hand, in spite of their fantastic vitality - neoplasic (cancerous) cells - because their mitosis is characteristically premature, consequently their mitochondria are notoriously underdeveloped, thus cannot generate biophotonic activity that could interact with their host. Nevertheless, their potential is sufficient to create an anarchic system -- which, in fact, is the very expression of such vitality that permits them to purposefully take advantage of this self-limiting aspect of the immune system.

Galle &. Cols. working at the German Center for Cancer Research in Heidelberg, showed that cancerous human hepatocytes can indeed produce FasL. They do this with the evident purpose of destroying T-lymphocytes and, probably, also to create true "safe zones", where the tumor cells are able to proliferate unimpeded, free of the immune systems deterrence.

Taking advantage of the virtually instantaneous biophotonic potential for data processing in the immune environment also in these cases, the components of appropriate thymic factors are able to efficiently oppose the enormous vitality of the neoplasic cells, orchestrating a virtual blockade that effectively and persistently obstructs the synthesis of FasL molecules, destined against alerts broadcasted by T-lymphocytes. They represent precisely those mechanisms that permit the participation of the thymus in the maturing of T-lymphocyte precursors and in the development of the cell-mediated immunity, which has acquired a renewed importance upon discovering that the inmunocompetence of thymectomized animals in neonatal phases, became restored by means of thymic tissue implants in cell-proof chambers, thus facilitating the macromolecular traffic.

Specially designed studies revealed that inmunologically deficient female rats recovered their capacity to induce implant-versus-host reactions, after the injection of semipurified thymic extracts free of cellular ballast. Moreover, satisfactory remissions were also produced in several metabolic deficiencies induced by thymectomies, administering thymic extracts of diverse animal origin.

It was precisely under this aegis that it was corroborated that the immune response generally diminishes notably when mitotic inhibitors or other toxic compounds are administered that antagonize biophotonic dynamics.

Subsequent to these findings, a variety of plant-derived factors were discovered, which, once incorporated in the serum of both, animals and of humans, evidently participate in the regulation of several physiological, thymus-effective processes. These essential vegetal factors were identified as sterols and their glucosides, sterolins the preparations used by the Author & Cols. were manifold freeze-dried, sprout-derived compounds containing virgin sterols and sterolins. Therapeutic studies, administering such sprout extracts, proved to be effective in treating of a growing variety of thymus-contingent immune pathologies.

It appears that the administration of virgin sterols and sterolins enhances the endogenous synthesis of thymic factors and of purified glycoproteinic substances - such as thymosin, and of pineal tissue - and provides the effective prerequisites to generate a very satisfactory modulation of the biophotonic signal potential, producing confirmed healing effects in numerous pathologic mechanisms of the cellular trophism and metabolism, particularly in degenerative diseases, in general immune disorders, in some types of primary cancer, and in numerous geriatric disorders, and very especially in reversing the course of immunosenescene.

NOTE: The clinical study is still ongoing and anticipated to be concluded and evaluated by mid-2000. The mean dosage of virgin sprout extracts containing sterols and sterolins is ranging from daily 1 to 3 grams administered orally in form of 350 mg capsules. Pertinent report of the clinical study should be available by mid-2000. A new trial targeting malaria with the same sprout extracts should begin in some Far Eastern countries in early 2000.

Bibliography available upon request.

(Lifeline Inc. reprint by permission from Peter R. Rothschild)